fbpx
Connect with us

Kaiser Health News

US to Cover HIV Prevention Drugs for Older Americans to Stem Spread of the Virus

Published

on

Michael Scaturro
Wed, 08 Nov 2023 10:00:00 +0000

A proposed federal policy aims to protect older Americans from contracting HIV by offering preventive medication, the latest effort to catch up to much of Europe and Africa in stemming the spread of the virus.

Under the plan from the Biden administration, Medicare would cover patients’ full cost of preexposure prophylaxis drugs, which prevent HIV transmission. The drugs, known by the shorthand “PrEP,” would be free in pill form and โ€” for the first time โ€” as long-acting injectables through the insurance program designed for those 65 and older. Those 50 and over make up half of all people in the U.S. already living with HIV.

The proposed policy change represents a big shift because it means that even new long-acting injectable versions of PrEP drugs, which can cost more than $20,000 a year in the U.S., would be covered fully, without requiring to kick in copayments. It is not yet clear what the plan would mean for taxpayers, though, either in paying for the medications or in offsetting the costs of caring for fewer Medicare patients with HIV in the future.

The final green light for the plan was expected Oct. 10, but the Centers for Medicare & Medicaid Services announced it is still working out details of how to transition coverage for patients already taking the drugs.

The U.S. is decades behind nations in Europe and Africa that are on track to end new HIV infections by 2030. But while the proposal should bring down infections in older Americans, it highlights remaining inequities: Many people under age 65 will still struggle to pay for PrEP. And, at the same time, Republican congressional leaders have threatened to cut funding for a federal HIV prevention effort championed by the Trump administration that is intended to help all at risk.

“We’ve done a very poor job in the U.S. of assuring that people who could most benefit from PrEP have access to it,” said Justin Smith, who directs the Campaign to End AIDS at Positive Impact Health Centers in the Atlanta area.

Though PrEP has been embraced by gay and trans Americans, it is prescribed less often to heterosexuals over 50 or women of any age. In the first three months of this year, just 8% of the more than 300,000 people receiving PrEP in the U.S. were women, according to the Centers for Disease Control and Prevention. The racial gap is large, too: While 66% of white people eligible for PrEP got prescriptions for it in that period, only 8% of eligible Black people and 17% of eligible Hispanic people did.

Broadening access for gay and bisexual of color, as well as straight and cisgender women of color โ€” particularly Black women, who represent the majority of women with HIV in the U.S. as well as the majority of new infections among women โ€” is critical for the nation to catch up to the rest of the world, Smith said.


RELATED ARTICLE


PrEP, a Key HIV Prevention Tool, Isn’t Reaching Black Women

New HIV infections occur disproportionately among Black women, but exclusionary marketing, fewer treatment options, and provider wariness have limited uptake of preexposure prophylaxis, or PrEP, drugs, which reduce the risk of contracting the virus.

Read More

Leisha McKinley-Beach, a national HIV consultant and of the Black Public Health Academy, which prepares Black health department employees for leadership positions, noted that the Medicare proposal to the cost of injectable PrEP could help many women because a shot given every two months can be easier to manage than a daily pill.

But it’s just a start. She and others are lobbying for a national PrEP plan that would build on momentum from the recent Medicare proposal to expand free access to other age groups, much as with covid-19 vaccinations. McKinley-Beach also wants the U.S. government to expand the message that anyone can get HIV, encourage drug companies to advertise more on TV to women of color, and fund outreach to dispel medical mistrust in communities of color.

“Gay white men have had a narrative of dignity and respect with regards to HIV treatment, and I would never want to change that narrative,” she said. “But the message needs to be broadened. Forty-two years into the HIV epidemic, the current HIV prevention model is detrimental to Black women who could benefit from PrEP.”

Though the U.S. was the first nation to approve PrEP, in 2012, it now trails the rest of the world in equitable access. That’s mostly due to the cost of laboratory tests and medical visits. While the cost of the generic form of Truvada, an oral form of PrEP, can be as low as about $30 a month in the U.S., a study by University of Virginia researchers reported the cost of starting PrEP is typically about $2,670 for uninsured patients, including about $1,000 for lab tests and medical visits. The new Medicare proposal would cover up to seven counseling visits every 12 months for HIV risk assessment and reduction.

Meanwhile, PrEP pills are free for people in the United Kingdom and European Union nations including France, Germany, Sweden, and Denmark. Those nations don’t yet cover the more expensive shots, although the U.K. is leading a small test on injectable PrEP in people who cannot take it in tablet form.

The U.S. also lags Western Europe and some nations in Africa in overall HIV treatment and prevention. For example, just 57% of HIV-positive Americans have attained viral suppression, according to the U.S. government website HIV.gov, meaning they regularly take medications to make them unable to transmit the virus. That makes PrEP, which is for people who don’t have the virus, all the more important for Americans to stay negative, according to HIV experts.

In Africa, by contrast, Botswana, Eswatini (formerly Swaziland), Rwanda, Tanzania, and Zimbabwe have already achieved the United Nations’ “95-95-95” targets set for 2025 โ€” 95% of people with HIV know their HIV status, 95% of people with diagnosed HIV infection sustained antiretroviral therapy, and 95% of people receiving antiretroviral therapy have achieved viral suppression, or the virus is undetectable in their blood โ€” according to the U.N.

In the U.K., 98% of HIV-positive people have achieved “undetectable” status via free antiretroviral medicines and treatment available through the country’s universal health care program, the National Health Service. Moreover, nearly anyone in the U.K. who is HIV-negative and wants to take PrEP can get it at no charge. The U.K. says it is now on a path to reduce new HIV infections by 80% by 2025.

The U.K. changed its PrEP approach after 2015, when Greg Owen founded “iwantprepnow.co.uk,” a website that ignited a PrEP movement by helping people in the U.K. and Europe self-source low-priced generic forms of Truvada, the first drug approved as PrEP, from pharmacies in Hong Kong and India.

“It became more affordable,” said Owen, now PrEP lead at one of the U.K.’s top HIV and sexual health charities, Terrence Higgins Trust. “Soon people demanded it for free on the NHS.”

In the U.S., Smith said, the lack of a national PrEP program that would make the drugs and associated bloodwork free and a heated political climate around health care have hindered HIV outreach.

“In rural of the South, especially in places like Georgia or Tennessee, there has been outright hostility toward accepting money from the CDC and expanding Medicaid to treat and prevent HIV,” Smith said. “People think it’s just , but this is having an impact on public health, on people’s lives.”

Anti-queer sentiment in many quarters also creates an environment of hostility around overall sexual health, said Richard Elion, director of clinical research at Washington Health Institute and a professor at George Washington University School of Medicine and Health Sciences. “There’s a chilling effect for everyone, not just queer Americans,” he said.

Elion said shame surrounding sex and the feeling of vulnerability that some people get from taking any medicine may also reduce PrEP uptake among older Americans. “Taking PrEP is actually very empowering, and that needs to be the message,” he said.

——————————
By: Michael Scaturro
Title: US to Cover HIV Prevention Drugs for Older Americans to Stem Spread of the Virus
Sourced From: kffhealthnews.org//article/prep-hiv-prevention-drugs-medicare-coverage-biden/
Published Date: Wed, 08 Nov 2023 10:00:00 +0000

Kaiser Health News

As Nuns Disappear, Many Catholic Hospitals Look More Like Megacorporations

Published

on

kffhealthnews.org – Samantha Liss – 2024-11-05 04:00:00

SUMMARY: No nuns currently serve as CEOs in over 600 Catholic hospitals in the U.S., despite their historical role in establishing these institutions. As the focus on financial viability intensified, many hospitals transformed into large for-profit entities, straying from their original charitable missions. Sister Mary Jean Ryan, a prominent former leader at SSM , emphasized the critical role nuns played in leadership. Current Catholic hospital executives, led by Laura Kaiser, earn significant salaries, raising questions about their commitment to community welfare. While Catholic doctrine influences care practices, the hospitals’ tax-exempt status and community contributions are often questioned, highlighting disparities between mission and profit.

Read the full article

The post As Nuns Disappear, Many Catholic Hospitals Look More Like Megacorporations appeared first on kffhealthnews.org

Continue Reading

Kaiser Health News

Election Outcome Could Bring Big Changes to Medicare

Published

on

kffhealthnews.org – Stephanie Armour – 2024-11-04 03:00:00

SUMMARY: During the campaign, both Donald Trump and Kamala Harris are positioning themselves as defenders of Medicare, each blaming the other for potential cuts to the program. The election could significantly impact Medicare’s future, especially with more beneficiaries opting for Medicare Advantage plans by private insurers, a trend that could escalate under a Trump administration. Critics warn that increased privatization would limit care options and raise costs, while supporters argue these plans better . Polls indicate that a candidate’s stance on Medicare heavily influences voter decisions, highlighting the program’s importance in the upcoming election.

Read the full article

The post Election Outcome Could Bring Big Changes to Medicare appeared first on kffhealthnews.org

Continue Reading

Kaiser Health News

Whatโ€™s at Stake: A Pivotal Election for Six Big Health Issues

Published

on

kffhealthnews.org – Arthur Allen and Phil Galewitz, KFF and Julie Rovner, KFF Health News and Daniel Chang – 2024-11-01 14:24:00

SUMMARY: In the election campaign’s final days, Vice President Kamala Harris and former clash over , issues of access and the Affordable Care Act (ACA). Harris aims to preserve ACA subsidies and protect health care rights, while Trump’s campaign lacks clarity on health plans, suggesting significant cuts. The future of , drug prices, and transgender health care also hinges on the election outcome. Trump’s proposals could roll back protections for these groups, contrasting with Harris’ promises to uphold existing health care rights and enhance drug pricing negotiations, setting stark differences for voters.

Read the full article

The post What’s at Stake: A Pivotal Election for Six Big Health Issues appeared first on kffhealthnews.org

Continue Reading

Trending